RTW INVESTMENTS, LP - 23 Sep 2022 Form 4 Insider Report for Landos Biopharma, Inc.

Role: 10%+ Owner
Signature: RTW Investments, LP, By: /s/ Roderick Wong, Managing Partner
Issuer symbol: N/A
Transactions as of: 23 Sep 2022
Net transactions value: -$207,000
Form type: 4
Filing time: 27 Sep 2022, 16:30:27 UTC
Previous filing: 09 Sep 2022
Next filing: 11 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LABP	Common Stock	Sale	$207,000	-300,000	-7%	$0.6900	3,975,722	23 Sep 2022	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

RTW INVESTMENTS, LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the shares of common stock held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser.

Remarks:

Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.